Denise Selegato
banner
deniseselegato.bsky.social
Denise Selegato
@deniseselegato.bsky.social
Metabolomics Specialist at the @ZimmermannLab.
📍Heidelberg, Germany
🇧🇷
Reposted by Denise Selegato
📍Paper alert 📍

Our new preprint is available on: chemrxiv.org/engage/chemr...

Here, we show the development of a GC-MS/MS method for the quantification of 120 compounds produced by gut bacteria, including SCFA, indols, organic acids, and amino acid derivatives.
Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites
The gut microbiota produces metabolites that are important for host physiology and have critical roles in the development of diseases, such as metabolic disorders, cardiovascular diseases, and cancer....
chemrxiv.org
September 24, 2025 at 12:21 PM
📍Preprint Alert 📍
February 11, 2026 at 10:30 PM
📍New Paper Alert 📍
February 11, 2026 at 10:30 PM
📍Preprint Alert 📍
Rewiring of oncogenic signaling in #DrugResistance is a moving target. In our new study, we used biophysical phosphoproteomics to investigate #BRAF mutant cancer, linking phosphorylation changes to protein function and #MolecularMechanisms through #Multi-Omics integration.
tinyurl.com/funsignaling
February 11, 2026 at 10:29 PM
Reposted by Denise Selegato
🚨 Do you work on microbial-mediated biotransformation of chemical compounds?
🧪 We would value your input to help us develop a standardized reporting framework for Xenobiotics–Microbiome interactions!

👉 Take the short survey (6–8 min): forms.gle/JNATejDrV2LR...

⬇️ ⬇️ ⬇️
MIX-MB (Minimum Information about Xenobiotics-Microbiome Biotransformation) - Community Consensus Survey
This survey aims to establish the Minimum Information about Xenobiotics-Microbiome Biotransformation (MIX-MB) reporting standards. As we move toward an era of AI-driven discovery, the structural and f...
forms.gle
February 9, 2026 at 1:05 PM